Five biosimilar manufacturers attack Millenium’s Entyvio patents in London
Some of the lawsuits against vedolizumab in the UK date back to early this year. Initially, Fresenius Kabi and Advanz Pharma filed revocation actions in February against most of the patents protecting the biologic (case IDs: HP-2026-000010 and HP-2026-000011).